pc 버전으로 이동 중 [시장보고서]세계의 체외 진단(IVD) 시약 시장 : 세계 산업 규모, 동향, 기회, 예측, 유형별, 기술별, 용도별, 최종 사용자별, 지역별, 경쟁별(2019-2029년)
세계의 체외 진단(IVD) 시약 시장 : 세계 산업 규모, 동향, 기회, 예측, 유형별, 기술별, 용도별, 최종 사용자별, 지역별, 경쟁별(2019-2029년)
In Vitro Diagnostic Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Technology, By Use, By End User, By Region and Competition, 2019-2029F
상품코드 : 1500101
리서치사 : TechSci Research
발행일 : 2024년 06월
페이지 정보 : 영문 180 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,900 ₩ 6,847,000
Unprintable PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 5,900 ₩ 8,244,000
PDF and Excel (Multi-User License) help
PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.
US $ 8,900 ₩ 12,436,000
PDF and Excel (Custom Research License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

체외 진단(IVD) 시약 시장은 2023년에 767억 5,000만 달러로 평가되었으며, 2029년까지 복합 연간 성장률(CAGR) 5.05%로 예측 기간 동안 눈부신 성장이 예측됩니다.

체외 진단(IVD) 시약 시장은 건강 관리 산업의 중요한 부문이며 정확한 질병 진단 및 환자 관리에 필수적입니다. 체외 진단용 시약은 신체의 다양한 질병과 상태를 검출하는 임상 검사에 사용되는 중요한 구성 요소이며, 임상의에 효과적인 치료를 결정하는 중요한 정보를 제공합니다. 이 시장은 현대 건강 관리의 중요성을 돋보이게 하는 몇 가지 요인들로 인해 현저한 성장과 다양화를 이루고 있습니다. IVD 시약 시장의 주요 촉진요인은 만성 질환의 세계 확산입니다. 당뇨병, 심혈관 질환, 암, HIV와 간염 등의 감염증이 증가하고 있습니다. IVD 시약은 이러한 질병의 진단에 중요한 역할을 하며 조기 발견, 질병 모니터링 및 치료 평가를 가능하게 합니다. 만성 질환의 이환율이 계속 증가함에 따라 IVD 시약이 제공하는 고급 진단 도구에 대한 수요가 증가하고 있습니다.

시장 개요
예측 기간 2025-2029
시장 규모 : 2023년 767억 5,000만 달러
시장 규모 : 2029년 1,033억 9,000만 달러
복합 연간 성장률(CAGR) : 2024년-2029년 5.05%
급성장 부문 면역 측정
최대 시장 북미

시장 성장을 촉구하는 또 다른 요인은 질병의 조기 발견이 중요하다는 것입니다. 적시 진단은 효과적인 질병 관리와 환자의 예후 개선에 필수적입니다. IVD 시약은 질병의 조기 발견을 촉진하고 신속한 개입과 개인화된 치료 계획을 가능하게 합니다. 조기 진단은 치료 성공률을 높일뿐만 아니라 합병증과 입원을 예방하여 건강 관리 부담을 줄입니다. 진단 기술의 발전은 IVD 시약 시장에 혁명을 가져왔습니다. 분자진단, 면역분석, 차세대 시퀀싱 등의 기술 혁신으로 진단 검사의 정확성과 감도가 향상되었습니다. IVD 시스템 자동화와 실험실 정보 관리 시스템과의 통합은 진단 실험실에서 워크플로우의 효율성을 높여줍니다.

세계 노인 인구 증가도 시장 성장에 기여합니다. 고령자는 만성 질환이나 감염증에 걸리기 쉽고, 노화 관련 병태를 감시,관리하기 위한 진단 검사에 대한 수요가 높아지고 있습니다. IVD 시약은 노인 건강 관리에서 중요한 역할을 하며 질병의 조기 발견과 관리를 지원합니다. 맞춤형 의료 및 유전체학에서 IVD 시약의 용도 확대가 시장 확대를 뒷받침하고 있습니다. 개인화된 의료는 체외 진단용 의약품이 제공하는 정확한 진단 정보에 의존하고, 표적 치료를 안내하고 치료 결과를 최적화합니다. 체외 진단용 의약품 시장은 정확한 질병 진단과 환자 관리의 필요성으로 인해 지속적인 혁신과 성장을 특징으로 합니다. 기술 발전, 질병 증가, 노화, 맞춤형 의료 및 유전체학 분야에서의 용도 확대로 시장은 지속적인 성장과 개발 태세를 갖추고 있습니다.

주요 시장 성장 촉진요인

진단 기술의 진보

개인화 및 게놈 의료 분야에서의 용도 확대

주요 시장 과제

급속한 기술 혁신

규정 준수

비용 압력

시장 세분화

주요 시장 동향

맞춤형 의료 통합

포인트 오브 케어 검사 확대

디지털화 및 데이터 분석

분자진단학의 진보

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계 체외 진단(IVD) 시약 시장 전망

제5장 아시아태평양의 체외 진단(IVD) 시약 시장 전망

제6장 유럽 체외 진단(IVD) 시약 시장 전망

제7장 북미의 체외 진단(IVD) 시약 시장 전망

제8장 남미의 체외 진단(IVD) 시약 시장 전망

제9장 중동 및 아프리카의 체외 진단(IVD) 시약 시장 전망

제10장 시장 역학

제11장 시장 동향과 발전

제12장 세계 체외 진단(IVD) 시약 시장 : SWOT 분석

제13장 Porter's Five Forces 분석

제14장 경쟁 구도

제15장 전략적 제안

제16장 기업 소개와 면책사항

BJH 24.07.04
영문 목차

영문목차

Global In Vitro Diagnostic (IVD) Reagents Market was valued at USD 76.75 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.05% through 2029. The In Vitro Diagnostic (IVD) Reagents Market is a critical segment within the healthcare industry, essential for accurate disease diagnosis and patient management. IVD reagents are vital components used in laboratory tests to detect various diseases and conditions in the body, providing clinicians with essential information for effective treatment decisions. The market has experienced significant growth and diversification, driven by several factors that highlight its importance in modern healthcare. A primary driver of the IVD Reagents Market is the increasing prevalence of chronic diseases globally. Conditions like diabetes, cardiovascular diseases, cancer, and infectious diseases such as HIV and hepatitis are on the rise. IVD reagents play a crucial role in diagnosing these diseases, enabling early detection, disease monitoring, and treatment assessment. As the incidence of chronic diseases continues to increase, there is a growing demand for advanced diagnostic tools provided by IVD reagents.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 76.75 Billion
Market Size 2029USD 103.39 Billion
CAGR 2024-20295.05%
Fastest Growing SegmentImmunoassay
Largest MarketNorth America

Another factor fueling market growth is the rising emphasis on early disease detection. Timely diagnosis is essential for effective disease management and improved patient outcomes. IVD reagents facilitate early disease detection, allowing for prompt intervention and personalized treatment plans. Early diagnosis not only enhances treatment success but also reduces healthcare burdens by preventing complications and hospitalizations. Technological advancements in diagnostics have revolutionized the IVD Reagents Market. Innovations such as molecular diagnostics, immunoassays, and next-generation sequencing have improved the precision and sensitivity of diagnostic tests. Automation and integration of IVD systems with laboratory information management systems have enhanced workflow efficiency in diagnostic laboratories.

The growing geriatric population worldwide has also contributed to market growth. Elderly individuals are more susceptible to chronic and infectious diseases, driving the demand for diagnostic tests to monitor and manage age-related conditions. IVD reagents play a vital role in geriatric healthcare, supporting early disease detection and management. Expanding applications of IVD reagents in personalized medicine and genomics have bolstered market expansion. Personalized medicine relies on accurate diagnostic information provided by IVD reagents, guiding targeted therapies and optimizing treatment outcomes. The IVD Reagents Market is characterized by continuous innovation and growth, driven by the need for accurate disease diagnosis and patient care. With advancements in technology, increasing disease prevalence, an aging population, and expanding applications in personalized medicine and genomics, the market is poised for sustained growth and development.

Key Market Drivers

Technological advancements in diagnostics

Technological advancements in diagnostics are driving the In Vitro Diagnostic (IVD) Reagents Market by enhancing the accuracy, speed, and breadth of diagnostic tests. Innovations such as molecular diagnostics, immunoassays, and automation have significantly improved the sensitivity and specificity of tests, enabling early and precise disease detection. Integration with digital platforms, data analytics, and artificial intelligence further optimize diagnostic processes, improving efficiency and outcomes. These advancements enable healthcare professionals to make informed decisions, enhancing patient care. Additionally, continuous research and development in diagnostic technologies foster the creation of new and improved IVD reagents, expanding the market's scope and ensuring its prominence in modern healthcare.

Expanding applications in personalized medicine and genomic

Expanding applications in personalized medicine and genomics are driving the In Vitro Diagnostic (IVD) Reagents Market by revolutionizing disease diagnosis and treatment. IVD reagents play a crucial role in genomic testing, biomarker analysis, and companion diagnostics, providing essential information for tailored therapies. As the healthcare industry shifts towards personalized medicine, these reagents enable precise identification of genetic markers and disease profiles, guiding targeted treatments and improving patient outcomes. The growing demand for personalized healthcare solutions propels the market, encouraging continuous research and development in IVD reagents. Their indispensable role in optimizing treatment strategies ensures a robust and expanding market presence in the realm of advanced medical diagnostics.

Key Market Challenges

Rapid Technological Changes

Rapid technological changes present a significant challenge for the In Vitro Diagnostic (IVD) Reagents Market. Continuous advancements in diagnostic technologies lead to frequent updates and introductions of new testing methods and reagents. Keeping up with these rapid changes requires substantial investments in research, development, and training for healthcare professionals. Additionally, integrating new technologies into existing healthcare systems poses logistical challenges, demanding seamless interoperability. Market players must balance innovation with practical implementation, ensuring that new reagents align with regulatory standards and meet the specific needs of diverse healthcare settings. Adapting swiftly to these technological shifts while maintaining quality and reliability remains a complex challenge in the dynamic IVD reagents landscape.

Regulatory Compliance

Regulatory compliance poses a significant challenge for the In Vitro Diagnostic (IVD) Reagents Market. Strict regulations govern the development, manufacturing, and distribution of diagnostic reagents to ensure their safety, efficacy, and accuracy. Navigating complex and evolving regulatory frameworks, varying from region to region, demands meticulous adherence to standards and extensive documentation. Meeting these requirements often entails substantial time and financial investments, delaying product launches and market entry. Additionally, keeping abreast of regulatory updates and policy changes is crucial. Companies must maintain rigorous quality control, conduct comprehensive testing, and engage in transparent reporting to satisfy regulatory authorities, making compliance a formidable challenge in the competitive and heavily regulated IVD reagents industry.

Cost Pressure

Cost pressure poses a significant challenge for the In Vitro Diagnostic (IVD) Reagents Market. Healthcare systems worldwide face budget constraints, compelling providers to seek cost-effective solutions without compromising quality. In this environment, IVD reagent manufacturers are under immense pressure to reduce production costs while maintaining high standards of accuracy and reliability. Price sensitivity among consumers and healthcare facilities further intensifies this challenge. Balancing affordability with innovation and quality necessitates efficient supply chain management, optimized manufacturing processes, and strategic pricing strategies. Companies must innovate not only in product development but also in cost-efficient production methods to remain competitive, addressing the industry's relentless cost pressures.

Market Fragmentation

Market fragmentation in the In Vitro Diagnostic (IVD) Reagents Market refers to the industry's division into numerous small and specialized segments. This fragmentation arises from the diverse range of diagnostic tests, each requiring specific reagents. With the constant evolution of medical technologies, diagnostic methods, and disease understanding, new, specialized tests continually emerge, catering to niche markets. As a result, the IVD reagents industry becomes fragmented, with various manufacturers focusing on specific tests or technologies. While this specialization allows for innovation, it also presents challenges in standardization, distribution, and market penetration, requiring companies to navigate a complex landscape to reach diverse customer needs effectively.

Key Market Trends

Personalized Medicine Integration

Personalized Medicine Integration stands out as a significant trend in the In Vitro Diagnostic (IVD) Reagents Market. With advancements in genomics and molecular diagnostics, IVD reagents are crucial in identifying specific genetic markers, enabling tailored treatments for individual patients. This trend emphasizes the need for highly precise and specialized diagnostic tools. By integrating personalized medicine approaches, healthcare providers can offer targeted therapies, optimizing treatment outcomes and minimizing adverse effects. IVD reagents play a pivotal role in this paradigm shift, providing the essential data necessary to customize treatment plans. As the trend toward personalized medicine gains momentum, the demand for innovative and accurate IVD reagents continues to rise, reshaping the landscape of diagnostic healthcare.

Point-of-Care Testing Expansion

Point-of-Care Testing (POCT) Expansion is a transformative trend in the In Vitro Diagnostic (IVD) Reagents Market, revolutionizing healthcare delivery. The growing emphasis on rapid and convenient diagnostic solutions has spurred the development of portable, easy-to-use testing devices. These advancements enable healthcare professionals to conduct diagnostic tests closer to patients, reducing turnaround times and enabling quicker interventions. IVD reagents tailored for POCT devices are essential, ensuring accurate and reliable results in diverse settings, from clinics to remote areas. The trend toward decentralized testing enhances accessibility, improves patient outcomes, and accelerates disease management, driving the demand for specialized IVD reagents designed for point-of-care applications and reshaping the IVD market landscape.

Digitalization and Data Analytics

Digitalization and Data Analytics have become pivotal trends in the In Vitro Diagnostic (IVD) Reagents Market, transforming the landscape of medical diagnostics. Advanced software and data analytics tools are being integrated with IVD reagents, enabling real-time monitoring, interpretation of test results, and predictive analysis. This integration enhances the efficiency of diagnostics, allowing for rapid and accurate interpretation of complex data sets. Healthcare providers can make informed decisions swiftly, leading to personalized patient care and improved outcomes. Additionally, digital platforms facilitate remote monitoring and telemedicine, expanding access to diagnostic services. As the industry embraces digitalization, the demand for IVD reagents compatible with these technologies continues to rise, driving market growth and innovation.

Molecular Diagnostics Advancements

Molecular Diagnostics Advancements are reshaping the In Vitro Diagnostic (IVD) Reagents Market, heralding a new era of precision and personalized medicine. The continuous evolution of molecular techniques, including polymerase chain reaction (PCR), nucleic acid sequencing, and gene expression profiling, enables the detection of specific DNA, RNA, and protein markers associated with diseases. IVD reagents play a central role in these advanced diagnostic methods, facilitating the identification of genetic mutations, infectious agents, and biomarkers linked to various conditions. These innovations enhance diagnostic accuracy, enabling early disease detection and targeted therapies. The demand for highly specialized IVD reagents, designed for molecular diagnostics, drives market growth, reflecting the industry's focus on cutting-edge, molecular-based healthcare solutions.

Segmental Insights

Technology Insights

Based on the Treatment, Immunoassays have established dominance in the In Vitro Diagnostic (IVD) Reagents Market due to their versatility, sensitivity, and wide applicability. These assays utilize antibodies to detect specific proteins, hormones, or antigens, enabling the diagnosis of a diverse range of diseases, including infectious, autoimmune, and hormonal disorders. Their accuracy, rapid results, and ability to measure multiple analytes simultaneously make them invaluable in clinical laboratories. Immunoassays also play a crucial role in cancer markers detection, cardiac biomarker testing, and allergy diagnostics. As a result, the demand for specialized IVD reagents for immunoassay platforms remains consistently high, making them the preferred choice for clinicians and diagnosticians worldwide.

Type Insights

Antibodies have become dominant in the In Vitro Diagnostic (IVD) Reagents Market due to their pivotal role in various diagnostic techniques. These specific proteins are crucial components of immunoassays, binding to specific antigens and enabling the accurate detection of diseases, pathogens, and biomarkers. Monoclonal antibodies, in particular, are engineered for high specificity and reproducibility, ensuring reliable diagnostic results. Their versatility allows for diverse applications, including infectious disease testing, cancer diagnostics, and autoimmune disorder screening. As the demand for precise and rapid diagnostics rises, the need for specialized IVD reagents featuring antibodies remains paramount, solidifying their dominance and indispensability in the IVD market.

Regional Insights

North America stands as the dominant region in the In Vitro Diagnostic (IVD) Reagents Market due to several factors. The region boasts advanced healthcare infrastructure, extensive research and development activities, and high healthcare spending, fostering the development of innovative diagnostic solutions. Additionally, a well-established pharmaceutical industry, supportive regulatory frameworks, and a large base of key market players contribute to the region's prominence. Moreover, a high prevalence of chronic diseases, rising awareness about early disease detection, and a favorable reimbursement scenario drive the demand for IVD reagents. These factors, combined with a sophisticated healthcare ecosystem and ongoing technological advancements, solidify North America's leading position in the global IVD reagents market.

Key Market Players

Thermo Fisher Scientific Inc

Becton, Dickinson and Company

Bio-Rad Laboratories, Inc

Agilent Technologies, Inc.

QIAGEN N.V.

Merck KGaA

Beckman Coulter, Inc

Hologic, Inc

Abcam Ltd

Bio-Techne Corp

Report Scope:

In this report, the Global In Vitro Diagnostic (IVD) Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

In Vitro Diagnostic (IVD) Reagents Market, By Type:

In Vitro Diagnostic (IVD) Reagents Market, By Technology:

In Vitro Diagnostic (IVD) Reagents Market, By Use:

In Vitro Diagnostic (IVD) Reagents Market, By End user:

In Vitro Diagnostic (IVD) Reagents Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the In Vitro Diagnostic (IVD) Reagents Market.

Available Customizations:

Global In Vitro Diagnostic (IVD) Reagents market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global In Vitro Diagnostic (IVD) Reagents Market Outlook

5. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Outlook

6. Europe In Vitro Diagnostic (IVD) Reagents Market Outlook

7. North America In Vitro Diagnostic (IVD) Reagents Market Outlook

8. South America In Vitro Diagnostic (IVD) Reagents Market Outlook

9. Middle East and Africa In Vitro Diagnostic (IVD) Reagents Market Outlook

10. Market Dynamics

11. Market Trends & Developments

12. Global In Vitro Diagnostic (IVD) Reagents Market: SWOT Analysis

13. Porter's Five Forces Analysis

14. Competitive Landscape

15. Strategic Recommendations

16. About Us & Disclaimer

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기